生物骇客市场规模、份额、成长分析、按产品、按应用、按最终用途、按地区 - 产业预测，2024-2031 年

Biohacking Market Size, Share, Growth Analysis, By Product, By Application, By End-use, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球生物骇客市场规模为207亿美元，从2023年的245.3亿美元成长到2031年的953.8亿美元，复合年增长率预计将成长18.50%。

近年来，由于基因组学、生物资讯学和神经技术的进步以及生物技术工具价格的下降，全球生物骇客市场经历了显着增长。这种增长吸引了各个领域的兴趣，包括医疗保健、体育和健身、製药、甚至军队以及寻求个人进步的个人。这种扩张的主要驱动力是对个人化医疗保健解决方案不断增长的需求。生物骇客分析遗传讯息、生物标记和其他生理资料，以做出有关饮食、运动和生活方式的明智决策，从而以资料主导的方式优化健康。这一趋势催生了直接面向消费者的基因检测套组、客製化营养计划以及监测各种健康指标的可穿戴设备等产品和服务。人们对认知增强的兴趣日益浓厚，进一步推动了市场的发展。随着人们寻求增强认知能力、记忆力、注意力和创造力，精神药物（被称为「智慧药物」）变得越来越受欢迎。这些物质与大脑训练和神经反馈技术一起越来越受欢迎。然而，生物骇客市场也面临挑战和伦理考虑，包括安全问题、监管问题以及严格科学检验的需要。此外，生物骇客技术的易用性和可承受性可能会影响其采用。总体而言，生物骇客市场是一个充满活力且不断发展的行业，融合了生物学、技术和 DIY 精神，以改善人类健康和表现。随着生物技术的不断进步以及消费者对个人化解决方案兴趣的不断增长，该市场预计将继续扩大并影响医疗保健和人类潜力的未来。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Apple Inc.
The ODIN
Thync Global Inc.
Nuanic
HVMN Inc.
Muse（Interaxon Inc.）
Thriveport, LLC
OsteoStrong
TrackMyStack
Synbiota Inc.（Canada）
Bulletproof 360, Inc.（US）
Keto Mojo（US）
Neurohacker Collective（US）
BioViva USA Inc.（US）
Quantified Self Labs, Inc.（US）
Moodmetric（Finland）
HumanCharger（Finland）
Modius Health（UK）
Emotiv Inc.（US）
Circadia Health（US）

简介目录

Product Code: SQMIG35H2217

Global Biohacking Market size was valued at USD 20.7 billion in 2022 and is poised to grow from USD 24.53 billion in 2023 to USD 95.38 billion by 2031, growing at a CAGR of 18.50% during the forecast period (2024-2031).

In recent years, the global biohacking market has experienced considerable growth, driven by advancements in genomics, bioinformatics, neurotechnology, and the increasing affordability of biotechnology tools. This growth has attracted interest from not only individuals seeking personal improvement but also from various sectors, including healthcare, sports and fitness, pharmaceuticals, and even the military. A major driver behind this expansion is the rising demand for personalized healthcare solutions. Biohackers use a data-driven approach to optimize their health, analyzing genetic information, biomarkers, and other physiological data to make informed decisions about their diet, exercise, and lifestyle. This trend has led to the creation of products and services such as direct-to-consumer genetic testing kits, customized nutrition plans, and wearable devices that monitor various health metrics. The growing interest in cognitive enhancement has further propelled the market. Nootropics, or "smart drugs," are becoming increasingly popular as individuals seek to boost their cognitive abilities, memory, focus, and creativity. These substances, along with brain-training techniques and neurofeedback technologies, are gaining traction. However, the biohacking market also faces challenges and ethical considerations, including safety concerns, regulatory issues, and the need for rigorous scientific validation. Additionally, the accessibility and affordability of biohacking technologies could impact their widespread adoption. Overall, the biohacking market represents a dynamic and evolving industry that merges biology, technology, and a DIY ethos to enhance human health and performance. With ongoing advancements in biotechnology and growing consumer interest in personalized solutions, the market is expected to continue its expansion and influence the future of healthcare and human potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biohacking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biohacking Market Segmental Analysis

Global Biohacking Market is segmented by Product, Application, application, end user and region. Based on Product, the market is segmented into Wearables, Implants, Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps, and Others. Based on Application, the market is segmented into Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis & Treatment, and Drug Testing. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Forensic Laboratories, and Research & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Biohacking Market

Advancements in biotechnology, genomics, and bioinformatics have equipped biohackers with powerful tools to explore and alter biological systems. These technological strides have facilitated the creation of novel biohacking technologies and interventions, allowing for more sophisticated approaches to personal and medical enhancements.

Restraints in the Global Biohacking Market

Biohacking frequently requires gathering and analyzing sensitive personal health information. Concerns about data breaches and privacy can undermine trust in the market, making individuals hesitant to share their data for biohacking activities. Such privacy issues can deter people from participating in biohacking initiatives, as fears about the security of their personal information become a significant barrier.

Market Trends of the Global Biohacking Market

The growing demand for personalized healthcare solutions is a major force driving the biohacking market. Consumers are increasingly leveraging genetic data, biomarkers, and physiological information to customize their health and lifestyle decisions. This trend has led to a rise in products such as genetic testing kits and personalized nutrition plans, as individuals seek more tailored approaches to managing their health and well-being.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Case study Analysis
PESTEL Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Biohacking Market by Product

Market Overview
Wearables
- Wearable Neurotech
- Oura Ring
- Muse Headband
- Others
Implants
- Blood Test Implant
- Circadia Implant
- NFC and RFID Tags
- Others
Gene Modification Kits
Smart Drugs
Supplements
Mobile Apps
Others

Biohacking Market by Application

Market Overview
Synthetic Biology
Genetic Engineering
Forensic Science
Diagnosis & Treatment
Drug Testing

Biohacking Market by End-use

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Forensic Laboratories
Research & Academic Institutes

Biohacking Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Apple Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The ODIN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thync Global Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuanic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HVMN Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Muse (Interaxon Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thriveport, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OsteoStrong
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TrackMyStack
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbiota Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bulletproof 360, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Keto Mojo (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurohacker Collective (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioViva USA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantified Self Labs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moodmetric (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HumanCharger (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Modius Health (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emotiv Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Circadia Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments